PEGylated biologics in haemophilia treatment: Current understanding of their long-term safety

被引：14

作者：

Baumann, Andreas ^{[1
]}

机构：

[1] Bayer AG, D-13342 Berlin, Germany

来源：

HAEMOPHILIA | 2020年 / 26卷 / 01期

关键词：

BIOPHARMACEUTICALS; PHARMACOKINETICS;

D O I：

10.1111/hae.13875

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E11 / E13

页数：3

共 10 条

[1] Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction [J].

Baumann, Andreas ;

Piel, Isabel ;

Hucke, Frank ;

Sandmann, Steffen ;

Hetzel, Terence ;

Schwarz, Thomas .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 130 :11-20

[2] Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis? [J].

Baumann, Andreas ;

Tuerck, Dietrich ;

Prabhu, Saileta ;

Dickmann, Leslie ;

Sims, Jennifer .

DRUG DISCOVERY TODAY, 2014, 19 (10) :1623-1631

[3] Pharmacokinetics, tissue distribution and excretion of 40 kDa PEG and PEGylated rFVIII (N8-GP) in rats [J].

Bjornsdottir, Inga ;

Sternebring, Ola ;

Kappers, Wendela A. ;

Selvig, Helle ;

Korno, Hanne T. ;

Kristensen, Jesper B. ;

Bagger, Morten A. .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 87 :58-68

[4]

European Medicines Agency, 2012, CHMP safety working party's response to the PDCO regarding the use of PEGylated drug products in the paediatric population

[5] PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development [J].

Ivens, Inge A. ;

Achanzar, William ;

Baumann, Andreas ;

Braendli-Baiocco, Annamaria ;

Cavagnaro, Joy ;

Dempster, Maggie ;

Depelchin, B. Olympe ;

Rovira, Armando R. Irizarry ;

Dill-Morton, Laura ;

Lane, Joan H. ;

Reipert, Birgit M. ;

Salcedo, Theodora ;

Schweighardt, Becky ;

Tsuruda, Laurie S. ;

Turecek, Peter L. ;

Sims, Jennifer .

TOXICOLOGIC PATHOLOGY, 2015, 43 (07) :959-983

[6] Nonclinical Safety Assessment of a Long-Acting Recombinant PEGylated Factor Eight (BAY 94-9027) With a 60 kDa PEG [J].

Ivensc, Inge A. ;

Banczyk, David ;

Gutberlet, Katrin ;

Jackman, Shawna ;

Vauleon, Stephanie ;

Frisk, Anna-Lena .

TOXICOLOGIC PATHOLOGY, 2019, 47 (05) :585-597

[7]

Jacobsen H, 2017, HERTF UK BIOSAFE EUR

[8] Outcome of Clinical Trials with New Extended Half-Life FVIII/IX Concentrates [J].

Mancuso, Maria Elisa ;

Santagostino, Elena .

JOURNAL OF CLINICAL MEDICINE, 2017, 6 (04)

[9]

Rasmussen CE, 2017, J TOXICOL-US, V2017, DOI 10.1155/2017/8496246

[10] PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs [J].

Turecek, Peter L. ;

Bossard, Mary J. ;

Schoetens, Freddy ;

Ivens, Inge A. .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) :460-475

← 1 →